Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
Sukhpreet Singh, Natalia A. Osna, Kusum K. Kharbanda
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6549-6570
Open Access | Times Cited: 229

Showing 1-25 of 229 citing articles:

Apoptosis and necroptosis in the liver: a matter of life and death
Robert F. Schwabe, Tom Luedde
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 12, pp. 738-752
Open Access | Times Cited: 470
Beneficial Effects of Betaine: A Comprehensive Review
Madan Kumar Arumugam, Matthew C. Paal, Terrence M. Donohue, et al.
Biology (2021) Vol. 10, Iss. 6, pp. 456-456
Open Access | Times Cited: 184
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Tom H. Karlsen, Nick Sheron, Shira Zelber‐Sagi, et al.
The Lancet (2021) Vol. 399, Iss. 10319, pp. 61-116
Open Access | Times Cited: 171
Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 106
Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease
Chuyun Yan, Wanting Hu, Jinqi Tu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé‐Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 57
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2844-2844
Open Access | Times Cited: 48
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 40
Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
Yuxin Yao, Yujie Yu, Shu Dai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116694-116694
Open Access | Times Cited: 19
Emerging Roles of Lipophagy in Health and Disease
Konstantinos Kounakis, Manos Chaniotakis, Maria Markaki, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 110
Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, et al.
Toxicology Reports (2021) Vol. 8, pp. 376-385
Open Access | Times Cited: 92
Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication
Zhanghao Li, Feixia Wang, Baoyu Liang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 90
Pharmacological properties of baicalin on liver diseases: a narrative review
Jinyu Yang, Min Li, Chengliang Zhang, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 5, pp. 1230-1239
Open Access | Times Cited: 79
Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review
Phaniendra Alugoju, V. K. D. Krishna Swamy, Naga Venkata Anusha Anthikapalli, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 31, pp. 10709-10774
Closed Access | Times Cited: 62
Long‐term exposure to air pollution and incident non‐alcoholic fatty liver disease and cirrhosis: A cohort study
Furong Li, Jian Liao, Bin Zhu, et al.
Liver International (2022) Vol. 43, Iss. 2, pp. 299-307
Closed Access | Times Cited: 49
Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway
Na Li, Lin Yin, Jiamin Shang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115113-115113
Open Access | Times Cited: 29
A promising therapy for fatty liver disease: PCSK9 inhibitors
Lizhu Han, Liuyun Wu, Qinan Yin, et al.
Phytomedicine (2024) Vol. 128, pp. 155505-155505
Closed Access | Times Cited: 9
Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances
Ana Catarina Sousa, Rui Alvites, Bruna Lopes, et al.
Journal of Functional Biomaterials (2025) Vol. 16, Iss. 1, pp. 28-28
Open Access | Times Cited: 1
Regulatory mechanisms of the probiotic-targeted gut–liver axis for the alleviation of alcohol-related liver disease: a review
Feiyu Yang, Xiangfei Li, Jing Sun, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-22
Closed Access | Times Cited: 1
Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action
In-Yong Jung, Hyerin Kim, Seongcheol Moon, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 857-857
Open Access | Times Cited: 70
Innate immune regulatory networks in hepatic lipid metabolism
Lan Bai, Hongliang Li
Journal of Molecular Medicine (2019) Vol. 97, Iss. 5, pp. 593-604
Closed Access | Times Cited: 68
Ameliorative and protective effects of ginger and its main constituents against natural, chemical and radiation-induced toxicities: A comprehensive review
Muhammad A. Alsherbiny, Wessam H. Abd-Elsalam, Shymaa A. El Badawy, et al.
Food and Chemical Toxicology (2018) Vol. 123, pp. 72-97
Closed Access | Times Cited: 66
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
Alessandro Federico, Marcello Dallio, Mario Masarone, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 60
Curcumin and Baicalin ameliorate ethanol‐induced liver oxidative damage via the Nrf2/HO‐1 pathway
Xiaoxia Wang, Xuhong Chang, Haibing Zhan, et al.
Journal of Food Biochemistry (2020) Vol. 44, Iss. 10
Open Access | Times Cited: 56
Mitochondrial Mechanisms of Necroptosis in Liver Diseases
Chen Xue, Xinyu Gu, Ganglei Li, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 66-66
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top